rs16868675

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001034850.3(RETREG1):​c.603T>C​(p.Cys201Cys) variant causes a synonymous change. The variant allele was found at a frequency of 0.0285 in 1,610,944 control chromosomes in the GnomAD database, including 2,289 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.076 ( 1056 hom., cov: 32)
Exomes 𝑓: 0.024 ( 1233 hom. )

Consequence

RETREG1
NM_001034850.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 5.08

Publications

9 publications found
Variant links:
Genes affected
RETREG1 (HGNC:25964): (reticulophagy regulator 1) The protein encoded by this gene is a cis-Golgi transmembrane protein that may be necessary for the long-term survival of nociceptive and autonomic ganglion neurons. Mutations in this gene are a cause of hereditary sensory and autonomic neuropathy type IIB (HSAN IIB), and this gene may also play a role in susceptibility to vascular dementia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]
RETREG1 Gene-Disease associations (from GenCC):
  • neuropathy, hereditary sensory and autonomic, type 2B
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 5-16481076-A-G is Benign according to our data. Variant chr5-16481076-A-G is described in ClinVar as Benign. ClinVar VariationId is 137274.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.221 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RETREG1NM_001034850.3 linkc.603T>C p.Cys201Cys synonymous_variant Exon 5 of 9 ENST00000306320.10 NP_001030022.1 Q9H6L5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RETREG1ENST00000306320.10 linkc.603T>C p.Cys201Cys synonymous_variant Exon 5 of 9 1 NM_001034850.3 ENSP00000304642.9 Q9H6L5-1

Frequencies

GnomAD3 genomes
AF:
0.0754
AC:
11460
AN:
152040
Hom.:
1044
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.224
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0332
Gnomad ASJ
AF:
0.00866
Gnomad EAS
AF:
0.00308
Gnomad SAS
AF:
0.00476
Gnomad FIN
AF:
0.00536
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0211
Gnomad OTH
AF:
0.0622
GnomAD2 exomes
AF:
0.0284
AC:
7045
AN:
248430
AF XY:
0.0247
show subpopulations
Gnomad AFR exome
AF:
0.225
Gnomad AMR exome
AF:
0.0190
Gnomad ASJ exome
AF:
0.0136
Gnomad EAS exome
AF:
0.00367
Gnomad FIN exome
AF:
0.00606
Gnomad NFE exome
AF:
0.0205
Gnomad OTH exome
AF:
0.0203
GnomAD4 exome
AF:
0.0236
AC:
34470
AN:
1458786
Hom.:
1233
Cov.:
30
AF XY:
0.0224
AC XY:
16224
AN XY:
725836
show subpopulations
African (AFR)
AF:
0.229
AC:
7628
AN:
33310
American (AMR)
AF:
0.0204
AC:
910
AN:
44582
Ashkenazi Jewish (ASJ)
AF:
0.0121
AC:
316
AN:
26042
East Asian (EAS)
AF:
0.00462
AC:
183
AN:
39634
South Asian (SAS)
AF:
0.00501
AC:
432
AN:
86216
European-Finnish (FIN)
AF:
0.00709
AC:
378
AN:
53294
Middle Eastern (MID)
AF:
0.0259
AC:
149
AN:
5750
European-Non Finnish (NFE)
AF:
0.0204
AC:
22622
AN:
1109716
Other (OTH)
AF:
0.0307
AC:
1852
AN:
60242
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
1467
2934
4401
5868
7335
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
930
1860
2790
3720
4650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0757
AC:
11514
AN:
152158
Hom.:
1056
Cov.:
32
AF XY:
0.0730
AC XY:
5435
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.224
AC:
9311
AN:
41486
American (AMR)
AF:
0.0331
AC:
505
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00866
AC:
30
AN:
3466
East Asian (EAS)
AF:
0.00309
AC:
16
AN:
5184
South Asian (SAS)
AF:
0.00477
AC:
23
AN:
4824
European-Finnish (FIN)
AF:
0.00536
AC:
57
AN:
10626
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0211
AC:
1432
AN:
67978
Other (OTH)
AF:
0.0616
AC:
130
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
473
945
1418
1890
2363
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0396
Hom.:
588
Bravo
AF:
0.0841
Asia WGS
AF:
0.0250
AC:
87
AN:
3478
EpiCase
AF:
0.0205
EpiControl
AF:
0.0199

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 06, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Neuropathy, hereditary sensory and autonomic, type 2B Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
13
DANN
Benign
0.66
PhyloP100
5.1
Mutation Taster
=76/24
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16868675; hg19: chr5-16481185; COSMIC: COSV104626867; API